EssilorLuxottica: Disclosure of transactions in own shares
Disclosure of transactions in own shares
Paris, France (April 13, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2025, EssilorLuxottica declares that on April 7, 2026, the following share buybacks were carried out:
| Name of the issuer | Identity code of the issuer | Day of the transaction | Identity code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares (€) * | Market (MIC Code) |
| ESSILORLUXOTTICA SA | 549300M3VH1A3ER1TB49 | 07/04/2026 | FR0000121667 | 24,907 | 189.9786 | XPAR |
| ESSILORLUXOTTICA SA | 549300M3VH1A3ER1TB49 | 07/04/2026 | FR0000121667 | 15,000 | 189.9333 | DXE |
| ESSILORLUXOTTICA SA | 549300M3VH1A3ER1TB49 | 07/04/2026 | FR0000121667 | 2,123 | 189.8500 | TQE |
| ESSILORLUXOTTICA SA | 549300M3VH1A3ER1TB49 | 07/04/2026 | FR0000121667 | 3,634 | 189.9000 | AQE |
| TOTAL | 45,664 | 189.9515 | ||||
* Rounded to four decimal places
Attachment
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Leios Therapeutics Announces Exclusive Licensing Agreement and Strategic Investment with Subsidiaries of China Medical System Holdings Ltd. for 10XB-101
- HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patients with MET-Overexpressing EGFR-mutated Lung Cancer i
- MOEA's DoIT Showcases 31 Innovative Technologies at Meet Greater South
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share